Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

1.

Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.

Han B, Hu J, Shen J, Gao Y, Lu Y, Wang T.

Eur J Pharmacol. 2013 Aug 15;714(1-3):83-8. doi: 10.1016/j.ejphar.2013.06.011. Epub 2013 Jun 18.

PMID:
23791614
[PubMed - indexed for MEDLINE]
3.

Effects of hydroxysafflor yellow A in the attenuation of MPTP neurotoxicity in mice.

Han B, Zhao H.

Neurochem Res. 2010 Jan;35(1):107-13. doi: 10.1007/s11064-009-0035-4. Epub 2009 Aug 13.

PMID:
19680807
[PubMed - indexed for MEDLINE]
4.

Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.

Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T.

Neuroscience. 2014 Jan 31;258:385-400. doi: 10.1016/j.neuroscience.2013.11.038. Epub 2013 Nov 27.

PMID:
24291725
[PubMed - indexed for MEDLINE]
5.

Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.

Zhu G, Wang X, Chen Y, Yang S, Cheng H, Wang N, Li Q.

Planta Med. 2010 Nov;76(16):1820-6. doi: 10.1055/s-0030-1249976. Epub 2010 May 27.

PMID:
20509103
[PubMed - indexed for MEDLINE]
6.

Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.

Sullivan AM, Opacka-Juffry J, Blunt SB.

Eur J Neurosci. 1998 Jan;10(1):57-63.

PMID:
9753113
[PubMed - indexed for MEDLINE]
7.
8.
9.

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.

Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, Seo JC, Leem K, Son YS, Kim YJ, Kim CJ, Kim YS, Chung JH.

Exp Neurol. 2003 Mar;180(1):93-8.

PMID:
12668152
[PubMed - indexed for MEDLINE]
10.

Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.

Yuan H, Sarre S, Ebinger G, Michotte Y.

Brain Res. 2004 Nov 5;1026(1):95-107.

PMID:
15476701
[PubMed - indexed for MEDLINE]
11.

The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.

Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT.

J Pharm Pharmacol. 2004 May;56(5):649-54.

PMID:
15142343
[PubMed - indexed for MEDLINE]
12.
13.

Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.

Lee JY, Kim SH, Ko AR, Lee JS, Yu JH, Seo JH, Cho BP, Cho SR.

Brain Res. 2013 Nov 6;1537:290-302. doi: 10.1016/j.brainres.2013.08.051. Epub 2013 Aug 30.

PMID:
23998987
[PubMed - indexed for MEDLINE]
14.

[Protective effect of alkaloids from Piper longum in rat dopaminergic neuron injury of 6-OHDA-induced Parkinson's disease].

Zheng L, Wang H, Ba YY, Liu HL, Wang M, Guo WW, Wu X, Yang H.

Zhongguo Zhong Yao Za Zhi. 2014 May;39(9):1660-5. Chinese.

PMID:
25095380
[PubMed - indexed for MEDLINE]
15.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):155-61.

PMID:
15790539
[PubMed - indexed for MEDLINE]
16.

GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.

Wang Y, Tien LT, Lapchak PA, Hoffer BJ.

Cell Tissue Res. 1996 Nov;286(2):225-33.

PMID:
8854891
[PubMed - indexed for MEDLINE]
17.
18.

Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.

Youdim MB, Stephenson G, Ben Shachar D.

Ann N Y Acad Sci. 2004 Mar;1012:306-25.

PMID:
15105275
[PubMed - indexed for MEDLINE]
19.

Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.

Yasuhara T, Shingo T, Muraoka K, Kobayashi K, Takeuchi A, Yano A, Wenji Y, Kameda M, Matsui T, Miyoshi Y, Date I.

J Neurosurg. 2005 Jan;102(1):80-9.

PMID:
15658100
[PubMed - indexed for MEDLINE]
20.

Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.

Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT.

Free Radic Res. 2005 Oct;39(10):1119-25.

PMID:
16298737
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk